Staying Real in Israel
Home of
"The Marty Roberts Show"

You might miss out on the world’s first vaccine and cure for cancer!!!

Breast cancer cells

If you want to boycott Israel, do so at your own risk…the risk of being left behind, swept back to the dark ages…stripped of most of the benefits of modern science, technology and medical research…much of which comes out of the tiny little country called ISRAEL…

Boycott Israel…No, I don’t think so…not if you have even half a brain…

Eureka: World’s First Vaccine and Cure For Cancer Developed by Israeli Medicine Company

The BIG NEWS of a Cancer Curing Drug is coming in from Israel.

Reprinted from techie-buzz.com

An Israeli company has come up with a vaccine against cancer that is both safe in terms of no side-effects and can be administered as a drug. Vaxil BioTherapeutics has developed a vaccine that is now undergoing clinical trials and not yet available in the market. It is being tested at Hadassah University Medical Center in Jerusalem and the trials could take as long as six years to conclude.

A vaccine that is also a drug

The vaccine also acts like a drug, i.e. it can be administered to a sick person as a cure. The vaccine is being tested against a form of blood cancer called multiple myeloma and it is generating enough success. Vaxil says that it could be used against other types of cancer as well, including the common prostrate and breast cancer. The primary immune technology, called VaxHit, can then be developed for other forms of cancer.

How the drug works

The problem with cancer is that the immune system of the body doesn’t know what exactly it should do. The Vaxil product, called ImMucin, “trains” the immune system to act in a specific way. Cancer cells have a marker called MUC1 that is unique to cancer cells only. ImMucin trains “T-cells” of our immune system to attack only those cells that are marked by the MUC1 marker. The success rate of the vaccine has not been revealed, but it is supposedly phenomenal. The diversification of the vaccine stems from the fact that MUC1 marks more than 90% of the different cancer cells. Furthermore, since only those cells marked with MUC1 are targeted, the drug has no side-effects and is completely safe to use.

This may be the ultimate magic bullet that scientists have been working towards for a long time. However, there are still a few clinical tests to go.
Vaxil’s Homepage: http://www.vaxilbio.com/

Cancer is a bear…
Chemo may save your life, but it is definitely no fun, and the complications can be horrible, not to mention life-threatening…

I am speaking from first-hand experience, here, winning my 6-year-long battle (so far, Thank G-d) with Stage 4 colon cancer, with the Grace of G-d and the wonders of Israeli medical treatment…

It truly is a situation where one can survive the disease, but be killed by the treatment…

So, thank you, again, Israeli medicine… (and you evil drug companies…)

Teva reports positive Phase III blood disease trial results

Teva obtained lipegfilgrastim through its acquisition of Germany’s Ratiopharm.

Reprinted from Globes.co.il

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) reported positive results in its Phase III clinical trial of lipegfilgrastim for the treatment of severe neutropenia, a blood disorder. Teva obtained lipegfilgrastim through its acquisition of Germany’s Ratiopharm. It is comparable to Neulasta, made by Amgen Inc. (Nasdaq: AMGN).

The Phase III trial was conducted on 200 breast cancer patients receiving four cycles of chemotherapy who received either lipegfilgrastim or Neulasta. The trial met the primary endpoint of reducing the duration of severe neutropenia.

Neutropenia is a blood disorder in which the number of white blood cells falls, causing increased susceptibility to bacterial infections. It can be either congenital or the result of a viral infection or side effect of a drug, including chemotherapy, or exposure to certain poisons.

Neulasta has annual worldwide sales of $3.56 billion.

Teva VP global branded products Prof. Yitzhak Peterburg said, “Teva is committed to the development of biologics and biosimilars, which make up one of the fastest growing segments of the global pharmaceutical market and offer efficacious yet more affordable treatment to all patients.”

Teva’s share price rose 1.1% on the TASE today to NIS 170, but fell 0.2% in early trading on Nasdaq to $50.12, giving a market cap of $44.7 billion.

Who would have thought? Researchers in both Israel and the UK have determined that the sudden exposure at night by flicking on a light just to go to the bathroom can cause changes that might well lead to cancer.

Apparently you’d be better off stubbing your toe on the way to the john, or even widdling just a wee bit on your bare toes, rather than turning on the light to avoid such unpleasant mishaps.

You makes your choices and you takes your chances…

Israel/UK Research says Switching off lights can avoid cancer

Switching off lights can avoid cancer

Simply turning on a light at night for a few seconds to go to the toilet can cause changes that might lead to cancer, scientists claim.

Reprinted from The Times of India

Researchers in the UK and Israel found that when a light is turned on at night, it triggers an “over-expression” of cells linked to the formation of cancer.

The tests were carried out on mice at Leicester University by geneticist Professor Charalambos Kyriacou. During the trial, a group of mice were exposed to a light for one hour. When compared with mice, who had been kept in the dark, changes were found in cells in the brain responsible for the circadian clock which controls body function.

“We believe that any turning on of artificial light in the night has an impact on the body clock. It’s a very sensitive mechanism. If you want to get up to go to the toilet, you should avoid reaching for the light switch. There are some plug-in lights that just glow, that are safe and you could use them as an alternative,” Rachel Ben-Shlomo, of the University of Haifa, was quoted as saying.